It is also possible that such anti-Notch antibodies may have value as inhibitors of stromal activities that support tumor cell growth, such as angiogenesis, which depends on a DLL4-Notch1 signaling axis [32], [69]. This evidence concerns the gene DLL4 and neoplasm.